Search Tag: biotechnology

Executive Health Management

Hill-Rom Appoints Dr. Dirk Ehlers New President, Trumpf Medical

2015 24 Sep

Hill-Rom Holdings, Inc.(NYSE:HRC) announced the appointment of Dr.Dirk Ehlers as President, Trumpf Medical.Before joining Hill-Rom, Ehlers, 54, was President and Chief Executive Officer of Eppendorf, a life science tools company, based in Germany. Prior to Eppendorf, Ehlers served as the Head of Professional Diagnostics with Roche Diagnostics, based in... Read more

IT Management

Life Sciences First New Company Under Google's Alphabet

2015 22 Aug

In a blog published this morning, Google's co-founder and Alphabet President Sergey Brin announced LIfe Sciences as the first new company created under the Alphabet umbrella. This does not come as a surprise since Alphabet CEO Larry Page had already announced that life sciences and biotechnology will be a core area of focus for the newly restructured... Read more

IMAGING Management

Nobel Laureate Will Discuss Present and Future of Nanomedicine for Imaging and Treatment

2015 22 Jan

Nobel laureate Martin Chalfie, PhD, will be the keynote speaker at Cedars-Sinai’s 3rd Nanomedicine for Imaging and Treatment Conference on 13-14 March 2015. The biennial event will bring together two dozen experts from around the world to discuss emerging trends in the study and treatment of diseases at the molecular and atomic levels.During the conference,... Read more

Pharmacy Management

Biosimilars: Billions in Sales and Savings by 2020

2014 01 Oct

According to new research from Thomson Reuters Bioworld, there are more than 700 follow-on biologic therapies currently in development. The new therapies are expected to generate approximately $100 billion in sales by the end of this decade. These projections demonstrate that the biopharmaceutical development industry is rapidly growing with 245 biopharmaceutical... Read more

Executive Health Management

Frost & Sullivan: Volume Rises, Value Falls for Healthcare M&A Deals

2014 13 May

Patent expiry, together with an increase in generic competition in the global pharmaceutical and biotechnology industry, is expected to bring a number of deals.According to newly released analysis from Frost & Sullivan entitled “Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry”, evolving conditions in the marketplace... Read more

Endorsed Companies